How to Help Your Patients Find Tymlos in Stock: A Provider's Guide

Your patient leaves the office with a Tymlos prescription. Days later, they call back frustrated: they can't find the medication, their pharmacy doesn't carry it, or their insurance is asking for documents you haven't sent yet. This is a common scenario — and it's entirely preventable with the right processes in place.

This guide walks through the practical steps you and your office staff can take to streamline Tymlos access for your patients from the moment you write the prescription.

Why Tymlos Access Is Different from Most Drugs

Tymlos (abaloparatide) is classified as a specialty medication. This means it is not dispensed at standard retail pharmacies. It is only available through specialty pharmacy networks that have the infrastructure to handle refrigerated medications, complex insurance coordination, and patient support services.

Additionally, unlike teriparatide (which has FDA-approved generic versions and broader retail distribution), abaloparatide has no generic alternative as of 2026. Every prescription goes through brand-name Tymlos, with its associated cost and access barriers.

Step 1: Route the Prescription to the Right Specialty Pharmacy

Before routing the prescription, identify the patient's insurance-preferred specialty pharmacy. Call the plan's pharmacy benefit line or check the plan's formulary portal. Common specialty pharmacy networks for Tymlos:

Accredo (Express Scripts / Cigna / Evernorth)

CVS Specialty

Walgreens Specialty Pharmacy

Optum Specialty Pharmacy

Biologics by McKesson

Sending the prescription directly from your EMR or e-prescribing platform to the correct specialty pharmacy — rather than letting the patient navigate this themselves — dramatically reduces delays and miscommunication.

Step 2: Submit a Complete Prior Authorization Request Immediately

Don't wait for the specialty pharmacy to initiate the PA. Submit it proactively at the time of prescribing. A complete, well-documented PA request leads to faster approvals and fewer appeals.

Include in every PA submission:

Recent DXA report with T-scores (lumbar spine, femoral neck, total hip)

Prior fracture history with imaging documentation if available

Medication history for prior osteoporosis treatments (drug, dose, duration, reason for stopping)

FRAX score or other validated risk tool

Clinical narrative explaining why Tymlos is the appropriate treatment choice for this patient

Note: Many plans limit cumulative PTH analog therapy to 24 months (teriparatide + Tymlos combined). If the patient has had prior teriparatide, document the total months used to clarify remaining eligibility.

Step 3: Enroll Patients in the Tymlos Savings Program at Prescribing

At the time you discuss Tymlos with your patient, also discuss cost and savings options. Cost surprise is a major driver of non-adherence. Providing the information upfront builds patient confidence and readiness.

Commercially insured patients: Tymlos Savings Card may reduce copay to $0/month. Enroll at tymloshcp.com or 1-855-243-6222.

Uninsured/underinsured: Radius Assist program can provide Tymlos at no cost for eligible patients. Phone: 1-866-896-5674.

Cash-pay patients: GoodRx coupons reduce the price to approximately $2,577-$2,852/month, compared to the $4,000+ list price.

Step 4: Leverage the Hub Service / Together with Tymlos Program

Radius Health / Ipsen offers a hub service program called Together with Tymlos. Your office can partner with this program to offload much of the access coordination work:

Insurance verification and benefit investigation

Prior authorization initiation and support

Specialty pharmacy coordination and routing

Patient enrollment in savings and assistance programs

Patient injection training and education support

Contact the hub: 1-866-896-5674 or tymloshcp.com/access-and-savings

Step 5: Refer Patients to medfinder If They Still Can't Find Tymlos

Despite your best routing efforts, some patients may still struggle to locate a specialty pharmacy that can fill their prescription in a timely manner. For these patients, medfinder for providers is a valuable referral tool. medfinder calls pharmacies near the patient to find which ones can fill the prescription, then texts results directly to the patient. This removes the burden of pharmacy hunting from both the patient and your staff.

Step 6: Ensure Injection Training and Adherence Support

Once Tymlos is in the patient's hands, adherence is the next challenge. The Tymlos pen is a once-daily subcutaneous self-injection into the periumbilical abdomen. Ensure your patient or a caregiver can perform the injection correctly before their first fill.

Key adherence counseling points:

Orthostatic hypotension can occur within 4 hours of injection, especially early in treatment — advise patients to sit or lie down after injection for initial doses

Each pen provides exactly 30 doses — patients should reorder 7-10 days before running out

Pen must be discarded after 30 days of use even if doses remain

Calcium and vitamin D supplementation should be taken if dietary intake is inadequate

Bottom Line for Providers

Access to Tymlos requires proactive coordination — but it is achievable for most patients when you route to the right specialty pharmacy, submit a complete PA at prescribing, and connect patients with savings programs upfront. For a detailed overview of the access landscape, see our Tymlos shortage guide for prescribers.